Form 4 for OPK OPKO HEALTH, INC.
Accepted 2024-07-26 00:00:00 ET · period of report 2024-07-24 · accession 0000950170-24-087036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-26 | 2024-07-24 | OPK | Logal Adam | CFO, Sr. VP | A - Grant | $0.00 | +437.5K | 616.7K | +244% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-24 | A | A | 437,500 | $0.00 | 616,662 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of OPKO common stock upon the vesting of the award. The restricted stock units vest 50% on the second anniversary of the grant date, then 25% on each of the following two years. |